MSFT vs PLUS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.
The company presents a stark dichotomy between strong growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While the stock is attractively valued with a PEG ratio of 0.82 and trades well below its growth-based intrinsic value of $165.2, the deterministic health markers and bearish technical trend suggest underlying instability. Strong revenue and earnings growth are currently offsetting these risks, but the low F-Score indicates a need for caution regarding cash flow or operational efficiency.
Compare Another Pair
Related Comparisons
MSFT vs PLUS: Head-to-Head Comparison
This page compares Microsoft Corporation (MSFT) and ePlus inc. (PLUS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.